Benlysta (belimumab) - GSK
Humira (adalimumab) - Eisai, AbbVie
blisibimod (A-623) - Anthera Pharma
ianalumab (VAY736) - MorphoSys, Novartis
https://www.eventclass.org/contxt_ehsf2023/scientific/online-program/session?s=PS-01
 
Sabat R.1; Simaite D.2; Gudjonsson J. E.3; Brembach T.-C.1; Krause T.1; Salinas G.4; Witte K.1; Kokolakis G.1; Nikolaou C.1; Leeuw T.2; Coulibaly B.7; Levin C.7; Ghoreschi K.6; Rill N.1; Herrmann M.2; Bartnik E.2; Volk H.-D.5; Wolk K.1
 
Feb 2, 2023
 
Prev Next